Finance
Travere Therapeutics stock hits 52-week high at 43.33 USD
Travere Therapeutics stock hits 52-week high at 43.33 USD
I
Investing.com
May 1, 2026·1 min read
GM
FinanceTravere Therapeutics stock hits 52-week high at 43.33 USD
Original article
Travere Therapeutics stock hits 52-week high at 43.33 USD
Published by Investing.com